As expected, opponents of a $1 billion expansion at Boston Children's Hospital have filed an administrative appeal of the state's approval of the project.
Clinical-stage drug company RXi Pharmaceuticals Corp. reported on Thursday it has kept its ongoing cash burn in line with projections while moving development programs forward and closing in on a recently announced acquisition.
Holliston's Biostage will need to raise more money to get to human trials of its bioengineered organ implants to treat throat cancers as its third quarter losses exceed $3 million with a little over $6 million left in cash on hand.
The second-largest healthcare provider in the state is making moves to extended outside of its Eastern Massachusetts stronghold through a new partnership with a 200 physician independent practice association based in Central Massachusetts.